Terms: = Thyroid cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1
531 results:
1. Functional analysis of ESM1 by shRNA-mediated knockdown of its expression in papillary thyroid cancer cells.
Xie L; He L; Zhang W; Wang H
PLoS One; 2024; 19(4):e0298631. PubMed ID: 38626010
[TBL] [Abstract] [Full Text] [Related]
2. An enzyme-free sensing platform for miRNA detection and in situ imaging in clinical samples based on DNAzyme cleavage-triggered catalytic hairpin assembly.
Wang H; Shen M; Shen X; Liu J; Huang W; Jiang X; Liu H; Zeng S; Nan K; Cai S
Biosens Bioelectron; 2024 Jul; 256():116279. PubMed ID: 38608496
[TBL] [Abstract] [Full Text] [Related]
3. MYB/LINC00092 regulatory axis promotes the progression of papillary thyroid carcinoma.
Cheng L; Deng X; Le Y
Endokrynol Pol; 2024; 75(1):27-34. PubMed ID: 38497387
[TBL] [Abstract] [Full Text] [Related]
4. lncRNA HCG22 regulated cell growth and metastasis of papillary thyroid cancer via negatively modulating miR-425-5p.
Cao X; Ma C; Wu Y; Huang J
Endokrynol Pol; 2024; 75(1):20-26. PubMed ID: 38497386
[TBL] [Abstract] [Full Text] [Related]
5. [Stratified application of gene expression in diagnosis of thyroid nodules].
Guan WY; Zheng JY; Nie L; Wu HY
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):264-268. PubMed ID: 38433054
[No Abstract] [Full Text] [Related]
6. Identification of Germline
Pires C; Saramago A; Moura MM; Li J; Donato S; Marques IJ; Belo H; Machado AC; Cabrera R; Grünewald TGP; Leite V; Cavaco BM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396644
[TBL] [Abstract] [Full Text] [Related]
7. Sublethal thermal stress promotes migration and invasion of thyroid cancer cells.
Kuo CY; Tsai CH; Wu JK; Cheng SP
PLoS One; 2024; 19(2):e0298903. PubMed ID: 38394093
[TBL] [Abstract] [Full Text] [Related]
8. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
9. RNA Profile of Cell Bodies and Exosomes Released by Tumorigenic and Non-Tumorigenic thyroid Cells.
Maggisano V; Capriglione F; Mio C; Bulotta S; Damante G; Russo D; Celano M
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338696
[TBL] [Abstract] [Full Text] [Related]
10. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
11. Apatinib weakens proliferation, migration, invasion, and angiogenesis of thyroid cancer cells through downregulating pyruvate kinase M2.
Yang X; Li W; Han X; Wang J; Dai J; Ye X; Meng M
Sci Rep; 2024 Jan; 14(1):879. PubMed ID: 38195651
[TBL] [Abstract] [Full Text] [Related]
12. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
13. Fasting regulates mitochondrial function through lncRNA PRKCQ-AS1-mediated IGF2BPs in papillary thyroid carcinoma.
Zhang X; Zhong Y; Liu L; Jia C; Cai H; Yang J; Wu B; Lv Z
Cell Death Dis; 2023 Dec; 14(12):827. PubMed ID: 38092752
[TBL] [Abstract] [Full Text] [Related]
14. Canagliflozin reduces thyroid cancer cells migration in vitro by inhibiting CXCL8 and CCL2: An additional anti-tumor effect of the drug.
Coperchini F; Greco A; Croce L; Pignatti P; Muzza M; Petrosino E; Teliti M; Magri F; Rotondi M
Biomed Pharmacother; 2024 Jan; 170():115974. PubMed ID: 38056240
[TBL] [Abstract] [Full Text] [Related]
15. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in thyroid cancer Cells.
Zhang Y; Han Y; Dong J; Li F; Sun Y
Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
[TBL] [Abstract] [Full Text] [Related]
16. Customized fluorescent probe for peering into the expression of butyrylcholinesterase in thyroid cancer.
Kang W; Ma M; Xu L; Tang S; Li J; Ma P; Song D; Sun Y
Anal Chim Acta; 2023 Nov; 1282():341932. PubMed ID: 37923409
[TBL] [Abstract] [Full Text] [Related]
17. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
Wang D; Liu X; Li M; Ning J
Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
[TBL] [Abstract] [Full Text] [Related]
18. CRISPR/Cas9-mediated high-mobility group A2 knockout inhibits cell proliferation and invasion in papillary thyroid carcinoma cells.
Jin S; Yong H; Liu Y; Bao W
Adv Med Sci; 2023 Sep; 68(2):409-416. PubMed ID: 37837800
[TBL] [Abstract] [Full Text] [Related]
19. Circular RNA eukaryotic translation initiation factor 6 facilitates tpc-1 cell proliferation and invasion through the microRNA-138-5p/lipase H axis.
Yi D; Zhang D; Zeng Z; Zhang S; Song B; He C; Li M; He J
Funct Integr Genomics; 2023 Sep; 23(4):313. PubMed ID: 37776372
[TBL] [Abstract] [Full Text] [Related]
20. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
PeerJ; 2023; 11():e16054. PubMed ID: 37744220
[TBL] [Abstract] [Full Text] [Related]
[Next]
